Thomas M. Grogan
Corporate Officer/Principal presso University of Arizona
Profilo
Thomas M.
Grogan founded Ventana Medical Systems, Inc. in 1985, where he worked as Chairman-Emeritus & SVP-Medical Affairs from 1985 to 2008 and Roche Tissue Diagnostics in 1985.
Dr. Grogan also currently works at the University of Arizona, as Professor from 1979.
Dr. Grogan also formerly worked at ReadCoor, Inc., as Director from 2017.
Posizioni attive di Thomas M. Grogan
| Società | Posizione | Inizio |
|---|---|---|
| University of Arizona | Corporate Officer/Principal | 01/01/1979 |
Precedenti posizioni note di Thomas M. Grogan
| Società | Posizione | Fine |
|---|---|---|
ReadCoor, Inc.
 ReadCoor, Inc. Internet Software/ServicesTechnology Services ReadCoor, Inc. operates sequencing platform. The firm develops Fluorescence In-situ Sequencing technology, which enables integration of high throughput sequencing, morphometric analysis, cellular location and three dimensional spatial imaging. The company was founded by Richard Terry, Marcell M. Shawn, Evan R. Daugharthy, and George M. Church in 2014 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Roche Tissue Diagnostics
 Roche Tissue Diagnostics Medical/Nursing ServicesHealth Services Roche Tissue Diagnostics provides diagnostic services. The private company is based in Basel, Switzerland. The Swiss company was founded in 1985 by Thomas M. Grogan. | Fondatore | - |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
ReadCoor, Inc.
ReadCoor, Inc. Internet Software/ServicesTechnology Services ReadCoor, Inc. operates sequencing platform. The firm develops Fluorescence In-situ Sequencing technology, which enables integration of high throughput sequencing, morphometric analysis, cellular location and three dimensional spatial imaging. The company was founded by Richard Terry, Marcell M. Shawn, Evan R. Daugharthy, and George M. Church in 2014 and is headquartered in Cambridge, MA. | Technology Services |
Roche Tissue Diagnostics
Roche Tissue Diagnostics Medical/Nursing ServicesHealth Services Roche Tissue Diagnostics provides diagnostic services. The private company is based in Basel, Switzerland. The Swiss company was founded in 1985 by Thomas M. Grogan. | Health Services |
- Borsa valori
- Insiders
- Thomas M. Grogan
